Indomethacin Injection Market: By Medical Use (Rheumatoid Arthritis, Ankylosing Spondylitis, Osteoarthritis, Gouty Arthritis, Acute painful shoulder bursitis or tendinitis, Headaches, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography

 

Indomethacin Injection Market size was valued at USD 213.4 million in 2021 and is poised to grow at a significant CAGR of 7.6% over 2022–2028. For a long time, NSAIDs have been an essential treatment for the symptoms of osteoarthritis. NSAIDs exert anti-inflammatory and analgesic effects by allowing the prostaglandin-producing enzyme cyclooxygenase to enter the body (COX). Backache and different joint aches are routinely treated with non-steroidal anti-inflammatory medications (NSAIDs). Injections of indomethacin are NSAIDs. Indomethacin is also used to treat a congenital heart condition known as patent ductus arteriosus in neonates (PDA). Furthermore, the elderly are more likely to experience joint pain. Injections such as platelet-rich plasma and indomethacin are useful in reducing pain and inflammation. Furthermore, in the elderly population, these illnesses will significantly minimize the chance of infection in the affected joint. As a result of these reasons, the market is expected to rise in the future years.